At ASN Kidney Week 2026, nephrologists said value-based kidney models improved dialysis starts, but payment cuts and MA growth are pushing practices out.
News|Articles|July 7, 2025
How AI Can Address the Troubled Business Model in Oncology
Author(s)Mary Caffrey
Fact checked by: Laura Joszt, MA
Artificial intelligence (AI) will transform community oncology, addressing workforce shortages and reimbursement challenges while enhancing patient care and operational efficiency, discussed speakers at Tennessee Oncology's “Tech Innovations in Community Oncology."
Advertisement
Advertisement
Flatiron Assist. LeanTaas. DeepScribe. Most US oncologists were years into practice when these technology companies took their first steps, starting about 15 years ago—the same year the
Related to this article
Povetacicept reduced proteinuria by 52% vs 4.3% with placebo at week 36 in adults with IgA nephropathy in the phase 3 RAINIER trial’s interim analysis.
At IDWeek 2026, IDSA and HIVMA leaders and clinician advocates outline how stories, relationships, and bipartisan outreach shape ID and HIV policy.
As CKCC nears its sunset, kidney care leaders urge CMS to preserve a dedicated, nephrologist-led accountable care model for advanced kidney disease.
Speakers at ASN Kidney Week urge nephrologists to appeal prior authorization denials, include children in trials, and expand access to glomerular disease therapies globally.
Legal and clinical experts examined the US medical aid in dying framework, its limits, and ethical debates.
Nearly half of working-age adults were inadequately insured in 2026, and half went without needed care due to cost, a Commonwealth Fund survey found.
Advertisement
Advertisement